Target Populations in Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases— A Workshop Accompanying: Cellular Therapy for Treatment of Autoimmune Diseases, Basic Science and Clinical Studies, Including New Developments in Hematopoietic and Mesenchymal Stem Cell Therapy
Year: 2006
Type: article
Abstract: After our recent discussion of feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease [1], important questions remained as to the patient populations that are most appropriate for such clinical trials. To consider the problem of patient selection further, many of the same international group of autoimmune disease experts and hematopoietic cell transplantation (HCT) physicians met as a workshop in Newport Beach, CA, in October 2005.
Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Cancer Institute, Felix Platter-Hospital, University Hospital of Basel, University of California, Los Angeles, City Of Hope National Medical Center, University of Washington, Fred Hutch Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2128598607